130 related articles for article (PubMed ID: 34993564)
21. Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.
Spratt DE; Suresh K; Osawa T; Schipper M; Jackson WC; Abugharib A; Lebastchi A; Smith D; Montgomery JS; Palapattu GS; Priya Kunju L; Wu A; Lew M; Tomlins SA; Chinnaiyan AM; Weizer AZ; Hafez KS; Kaffenberger SD; Udager A; Mehra R
Med Oncol; 2018 Jan; 35(3):21. PubMed ID: 29387987
[TBL] [Abstract][Full Text] [Related]
22. Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy.
Ko JJ; Bernard B; Tran B; Li H; Asif T; Stukalin I; Lee M; Day D; Alimohamed N; Sweeney CJ; Bedard PL; Heng DY
J Clin Oncol; 2016 Mar; 34(7):714-20. PubMed ID: 26786931
[TBL] [Abstract][Full Text] [Related]
23. Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.
Ruf CG; Gnoss A; Hartmann M; Matthies C; Anheuser P; Loy V; Pichlmeier U; Dieckmann KP
Andrology; 2015 Jan; 3(1):92-8. PubMed ID: 25146646
[TBL] [Abstract][Full Text] [Related]
24. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract][Full Text] [Related]
25. Body Mass Index and Outcomes in Germ-Cell Tumors.
McGregor BA; Miller RE; O'Donnell E; Albiges LK; Sweeney CJ; Markt SC
Clin Genitourin Cancer; 2019 Aug; 17(4):283-290. PubMed ID: 31129146
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil-to-lymphocyte ratio as a predictor of preoperative tumor staging in testicular germ cell tumors.
Jankovich M; Jankovichova T; Ondrus D; Breza J
Bratisl Lek Listy; 2017; 118(9):510-512. PubMed ID: 29061055
[TBL] [Abstract][Full Text] [Related]
27. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.
Feldman DR; Voss MH; Jacobsen EP; Jia X; Suarez JA; Turkula S; Sheinfeld J; Bosl GJ; Motzer RJ; Patil S
Cancer; 2013 Jul; 119(14):2574-81. PubMed ID: 23606402
[TBL] [Abstract][Full Text] [Related]
28. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
[TBL] [Abstract][Full Text] [Related]
29. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
[TBL] [Abstract][Full Text] [Related]
30. Re: First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
Richie JP
J Urol; 2015 Mar; 193(3):850. PubMed ID: 25765390
[No Abstract] [Full Text] [Related]
31. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.
Stang A; Jansen L; Trabert B; Rusner C; Eberle A; Katalinic A; Emrich K; Holleczek B; Brenner H;
Cancer Epidemiol; 2013 Aug; 37(4):492-7. PubMed ID: 23623488
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Miki T; Kamoi K; Fujimoto H; Kanayama HO; Ohyama C; Suzuki K; Nishiyama H; Eto M; Naito S; Fukumori T; Kubota Y; Takahashi S; Mikami K; Homma Y
Int J Urol; 2014 Aug; 21(8):S1-6. PubMed ID: 24725194
[TBL] [Abstract][Full Text] [Related]
33. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.
Ruf CG; Isbarn H; Wagner W; Fisch M; Matthies C; Dieckmann KP
Urol Oncol; 2014 Jan; 32(1):33.e1-6. PubMed ID: 23395239
[TBL] [Abstract][Full Text] [Related]
34. Analysis of clinical characteristics, treatment patterns, and outcome of patients with bilateral testicular germ cell tumors.
Azik H; Omri N; Kamil M; Miki H; Shay G; Roy M; Yuval F; Barak R; Ben S; Yariv S; Reuven BD; Gilad AE
Discov Oncol; 2024 Feb; 15(1):30. PubMed ID: 38321336
[TBL] [Abstract][Full Text] [Related]
35. Testicular germ cell tumors in patients with human immunodeficiency virus infection.
Hentrich MU; Brack NG; Schmid P; Schuster T; Clemm C; Hartenstein RC
Cancer; 1996 May; 77(10):2109-16. PubMed ID: 8640678
[TBL] [Abstract][Full Text] [Related]
36. Synchronous bilateral testicular germ cell tumors of different histologic type. Pathogenetic and practical implications of bilaterality in testicular germ cell tumors.
Reinberg Y; Manivel JC; Zhang G; Reddy PK
Cancer; 1991 Sep; 68(5):1082-5. PubMed ID: 1655215
[TBL] [Abstract][Full Text] [Related]
37. Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.
Pietzak EJ; Assel M; Becerra MF; Tennenbaum D; Feldman DR; Bajorin DF; Motzer RJ; Bosl GJ; Carver BS; Sjoberg DD; Sheinfeld J
Urology; 2018 Aug; 118():114-118. PubMed ID: 29704586
[TBL] [Abstract][Full Text] [Related]
38. Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital.
Sarikaya S; Karsiyakali N; Kaya E; Topuz B; Ebiloglu T; Zor M
Actas Urol Esp (Engl Ed); 2021; 45(1):30-38. PubMed ID: 33010987
[TBL] [Abstract][Full Text] [Related]
39. Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Zschäbitz S; Lasitschka F; Hadaschik B; Hofheinz RD; Jentsch-Ullrich K; Grüner M; Jäger D; Grüllich C
Eur J Cancer; 2017 May; 76():1-7. PubMed ID: 28262583
[TBL] [Abstract][Full Text] [Related]
40. [Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)].
Souchon R; Krege S; Schmoll HJ; Albers P; Beyer J; Bokemeyer C; Classen J; Dieckmann KP; Hartmann M; Heidenreich A; Höltl W; Kliesch S; Köhrmann KU; Kuczyk M; Schmidberger H; Weinknecht S; Winter E; Wittekind C; Bamberg M
Strahlenther Onkol; 2000 Sep; 176(9):388-405. PubMed ID: 11050912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]